BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs4950928
,
VEGFA
,
Angiogenesis
,
Hepatitis
,
Intestine
,
Neocentromeres
,
Cisplatin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
CTLA 4 antigen
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Regulatory T (Treg) cells and conventional T cells reponses to different factors and conditions
Explore Curated Studies Results
Literature
Most Relevant Literature
Immune-checkpoint blockade of CTLA-4 (CD152) in antigen-specific human T-cell responses differs prof…
Reprogramming the Intrahepatic Cholangiocarcinoma Immune Microenvironment by Chemotherapy and CTLA-4…
The gut microbiome and efficacy of cancer immunotherapy.
Monoclonal Antibodies to CTLA-4 with Focus on Ipilimumab.
Expanding the molecular and phenotypic spectrum of CTLA-4 insufficiency.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer
PARP-inhibition and CTLA-4 Blockade in BRCA-deficient Ovarian Cancer
PD-L1 Antibody Combined With CTLA-4 Antibody for Patients With Advanced Intrahepatic Cholangiocarcin…
XmAb23104 (PD1 X ICOS) and XmAb22841 (CTLA-4 X LAG3) in Treating Melanoma Prior Immune Checkpoint In…
Intradermal Injection of Anti-CTLA-4 in Patients With Stage I/II Melanoma
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ